Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

St. John's Wort in patients non-responders to clopidogrel undergoing percutaneous coronary intervention: a single-center randomized open-label trial (St. John's Trial).

Trana C, Toth G, Wijns W, Barbato E.

J Cardiovasc Transl Res. 2013 Jun;6(3):411-4. doi: 10.1007/s12265-013-9455-2. Epub 2013 Mar 6.

PMID:
23463297
2.

The neurocognitive effects of Hypericum perforatum Special Extract (Ze 117) during smoking cessation.

Camfield DA, Scholey AB, Pipingas A, Silberstein RB, Kure C, Zangara A, Kras M, Stough C.

Phytother Res. 2013 Nov;27(11):1605-13. doi: 10.1002/ptr.4909. Epub 2012 Dec 19.

PMID:
23280675
3.

Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity.

Fuchs I, Hafner-Blumenstiel V, Markert C, Burhenne J, Weiss J, Haefeli WE, Mikus G.

Eur J Clin Pharmacol. 2013 Mar;69(3):507-13. doi: 10.1007/s00228-012-1388-1. Epub 2012 Sep 12.

PMID:
22968811
4.

St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.

Sarris J, Fava M, Schweitzer I, Mischoulon D.

Pharmacopsychiatry. 2012 Nov;45(7):275-8. doi: 10.1055/s-0032-1306348. Epub 2012 May 16.

PMID:
22592504
5.

The evaluation of the clinical effect of topical St Johns wort (Hypericum perforatum L.) in plaque type psoriasis vulgaris: a pilot study.

Najafizadeh P, Hashemian F, Mansouri P, Farshi S, Surmaghi MS, Chalangari R.

Australas J Dermatol. 2012 May;53(2):131-5. doi: 10.1111/j.1440-0960.2012.00877.x. Epub 2012 Mar 8.

PMID:
22571563
6.

In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high antioxidant activity in vitro and ex vivo.

Meinke MC, Schanzer S, Haag SF, Casetti F, Müller ML, Wölfle U, Kleemann A, Lademann J, Schempp CM.

Eur J Pharm Biopharm. 2012 Jun;81(2):346-50. doi: 10.1016/j.ejpb.2012.03.002. Epub 2012 Mar 10.

PMID:
22430217
8.

Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group.

Chen JA, Papakostas GI, Youn SJ, Baer L, Clain AJ, Fava M, Mischoulon D.

J Clin Psychiatry. 2011 Dec;72(12):1669-76. doi: 10.4088/JCP.10m06453. Epub 2011 Oct 4.

PMID:
22053942
9.

The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide.

Fan L, Zhou G, Guo D, Liu YL, Chen WQ, Liu ZQ, Tan ZR, Sheng D, Zhou HH, Zhang W.

Clin Pharmacokinet. 2011 Sep;50(9):605-11. doi: 10.2165/11587310-000000000-00000.

PMID:
21827215
10.

St John's wort greatly decreases the plasma concentrations of oral S-ketamine.

Peltoniemi MA, Saari TI, Hagelberg NM, Laine K, Neuvonen PJ, Olkkola KT.

Fundam Clin Pharmacol. 2012 Dec;26(6):743-50. doi: 10.1111/j.1472-8206.2011.00954.x. Epub 2011 Jun 2.

PMID:
21635359
11.

The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.

Rapaport MH, Nierenberg AA, Howland R, Dording C, Schettler PJ, Mischoulon D.

J Psychiatr Res. 2011 Jul;45(7):931-41. doi: 10.1016/j.jpsychires.2011.05.001. Epub 2011 May 31.

12.

Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.

Singer A, Schmidt M, Hauke W, Stade K.

Phytomedicine. 2011 Jun 15;18(8-9):739-42. doi: 10.1016/j.phymed.2011.02.016. Epub 2011 Apr 21.

PMID:
21514125
13.

Hypericum perforatum for the treatment of premenstrual syndrome.

Ghazanfarpour M, Kaviani M, Asadi N, Ghaffarpasand F, Ziyadlou S, Tabatabaee HR, Dehghankhalili M.

Int J Gynaecol Obstet. 2011 Apr;113(1):84-5. doi: 10.1016/j.ijgo.2010.11.007. No abstract available.

PMID:
21315349
14.

The effect of St John's Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity.

Lau WC, Welch TD, Shields T, Rubenfire M, Tantry US, Gurbel PA.

J Cardiovasc Pharmacol. 2011 Jan;57(1):86-93. doi: 10.1097/FJC.0b013e3181ffe8d0.

PMID:
20980920
15.

A randomized clinical trial of St. John's wort for smoking cessation.

Sood A, Ebbert JO, Prasad K, Croghan IT, Bauer B, Schroeder DR.

J Altern Complement Med. 2010 Jul;16(7):761-7. doi: 10.1089/acm.2009.0445.

16.
17.

St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.

Mannel M, Kuhn U, Schmidt U, Ploch M, Murck H.

J Psychiatr Res. 2010 Sep;44(12):760-7. doi: 10.1016/j.jpsychires.2010.01.010. Epub 2010 Feb 23.

PMID:
20181361
18.

The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.

Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L.

CNS Drugs. 2010 Mar;24(3):207-25. doi: 10.2165/11530120-000000000-00000.

PMID:
20155996
19.

St John's wort greatly reduces the concentrations of oral oxycodone.

Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Laine K, Neuvonen PJ, Olkkola KT.

Eur J Pain. 2010 Sep;14(8):854-9. doi: 10.1016/j.ejpain.2009.12.007. Epub 2010 Jan 27.

PMID:
20106684
20.

The effect of Hypericum perforatum on the wound healing and scar of cesarean.

Samadi S, Khadivzadeh T, Emami A, Moosavi NS, Tafaghodi M, Behnam HR.

J Altern Complement Med. 2010 Jan;16(1):113-7. doi: 10.1089/acm.2009.0317.

PMID:
20064022
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk